Skip to main content
SpringerLink
Log in

Circulating CD34+ hematopoietic progenitors in the harvesting peripheral blood stem cells; enhancement by recombinant human granulocyte colony-stimulating factor

  • Published:
Biotherapy

Abstract

The number of circulating progenitor cells increases during the period of hematopoietic recovery following myeloablative therapy. These progenitor cells were used for autologous transplantation in order to reconstitute hematopoiesis. As an indicator of the circulating progenitor cells, the number of granulocyte-macrophage colony forming units (CFU-GM), which is measured by means of a long-term cell culture, has been widely used. Recently, a cell surface marker, CD34, which can easily be measured by means of flowcytometry, was found to represent immature hematopoietic progenitor cells, which are very close to stem cells. Therefore, the relationship between the number of CD34 positive cells (CD34+ cells) and the number of CFU-GM in the peripheral blood following chemotherapy was studied in 9 patients selected to undergo autotransplantation. The number of peripheral blood CD34+ cells was found to be significantly correlated with that of CFU-GM (r = 0.81). When four out of 9 patients received recombinant human granulocyte-colony stimulating factor (rG-CSF) administration, a significant increase in the release of peripheral blood CD34+ cells as well as peripheral blood CFU-GM was observed (P<0.01). Thus, the measurement of CD34+ cells is useful for predicting the number of circulating CFU-GM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. To LB, Juttner CA. Peripheral blood stem cell autografting. A new therapeutic option for AML? 1987; Br J Haematol 66: 285–8.

    Google Scholar 

  2. Lasky LC. Hematopoietic reconstitution using progenitors recovered from blood. Transfusion 1989; 29:552–7.

    Google Scholar 

  3. Reiffers J, Leverger, Castaigne S, Tilly H, Marit G, Lepage E, Henon P, Douay L, Troussard X. Autologous blood stem cell transplantation in patients with haematological malignancies. Bone Marrow Transplant 1988; 3 (Suppl. 1): 51–3.

    Google Scholar 

  4. To LB. Assaying the CFU-GM in blood: Correlation between cell dose and haematopoietic reconstitution. Bone marrow transplant 1990; 5 (Suppl. 1):16–18.

    Google Scholar 

  5. Kessinger A, Armitage JO. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 1991; 77: 211–3.

    Google Scholar 

  6. Strauss LC, Rowley SD, La Russa VF, Sharkis SJ, Stuart RK, Civin CI. Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp Hematol 1986; 14: 878–82.

    Google Scholar 

  7. Civin CI, Banquerrigo ML, Atrauss LC, Loken MR: Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. Exp Hematol 1987; 15:10–17.

    Google Scholar 

  8. Baines P, Mayani H, Bains M, Fisher J, Hoy T, Jacobs A. Enrichment of CD34 (My10)-positive myeloid and erythroid progenitors from human marrow and their growth in cultures supplemented with recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol 1988; 16: 785–9.

    Google Scholar 

  9. Ema H, Suda T, Miura Y, Nakauchi H. Colony formation of clone-sorted human hematopoietic progenitors. Blood 1990; 75: 1941–6.

    Google Scholar 

  10. Siena S, Bregni M, Brando M, Ravagnani F, Bonadonna G, Gianni AM. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony stimulating factor. Blood 1989; 74: 1905–14.

    Google Scholar 

  11. Morstyn G, Cambell L, Souza LM, Alton NK, Keech J, Green M, Sheridan W, Metcalf D, Fox R. Effect of granulocyte colony-stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; i 667–71.

    Google Scholar 

  12. Makino S, Harada M, Akashi K, Inaba S, Taniguchi S, Shibuya T, Niho Y. A simplified method for cryopreservation of peripheral blood stem cells at −80°C without rate-controlled freezing. Bone marrow transplantation 1991; 8: 239–44.

    Google Scholar 

  13. Niho Y, Till JE, McCulloch EA. Granulopoietic progenitors in suspension culture. A comparison of stimulatory cells and conditioned media. Blood 1975; 45: 811–21.

    Google Scholar 

  14. Okamura S, Niho Y, Otsuka T, Kimura N, Yamano Y, Oka Y, Yamasaki K, Yanase T. Bone marrow fibroblast colony-forming cells (CFU-F) in patients with aplastic anemia. Acta Haematol Jpn 1984; 47: 1249–1256.

    Google Scholar 

  15. To LB, Haylock DN, Kimber RJ, Jutner CA. High level of circulating haematopoietic stem cells in very early remission from acute non-lymphocytic leukaemia and their collection and cryopreservation. Br J Haematol 1984; 58: 399–410.

    Google Scholar 

  16. Reiffers J, Bernard PH, David B. Successful autologous transplantation with circulating hemopoietic stem cells in a patient with acute leukemia. Exp Hematol 1986; 14: 312–5.

    Google Scholar 

  17. Kessinger A, Armitage JO, Smith DM, Landmark JD, Bierman PJ, Weissenburger DD. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 1989; 74: 1260–5.

    Google Scholar 

  18. Bostrom B, Lasky L, Moss TJ, Delmer LP, Ramsey NKC. Autologous peripheral blood stem cell transplantation in solid tumors. In Dicke K, Spitzer G, Zander A, eds.: Autologous Marrow Transplantation. Proceeding of fourth International Sympoisum. Houston, TX: MD Anderson Press 1988; 707.

    Google Scholar 

  19. Berenson RJ, Andrews RG, Bensinger WI, Kalamasz D, Knitter G, Buckner CD, Bernstein ID. Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest 1988; 81: 951–5.

    Google Scholar 

  20. Masaoka T, Takaku F, Kato S, Moriyama Y, Kodera Y, Kanamura A, Shimosaka A, Shibata H, Nakamura H. Recombinant human granulocyte colony-stimulating factor in allogeneic bone marrow transplantation. Exp Hematol 1989; 17: 1047–50.

    Google Scholar 

  21. Budel LM, Touw IP, Delwel R, Lowenberg B. Granulocyte colony-stimulating factor receptors in human acute myelocytic leukemia. Blood 1989: 2668-73.

  22. Kondo S, Okamura S, Asano Y, Harada M, Niho Y. Human granulocyte colony-stimulating factor receptors in acute myelogenous leukaemia. Eur J Haematol 1991; 46: 223–30.

    Google Scholar 

  23. Vellenga E, Young DC, Wagner K, Wiper D, Ostapovicz, Griffin JD. The effect of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood 1987: 69: 1771–6.

    Google Scholar 

  24. Asano Y, Okamura S, Shibuya T, Morioka E, Taniguchi S, Harada M, Niho Y. Effect of human G-CSF on clongenic cells in acute myeloblastic leukemia. Eur J Cancer Clin Oncol 1988; 24: 1285–7.

    Google Scholar 

  25. Okamura S, Hayashi S, Kawasaki C, Kondo S, Asano Y, Omori F, Otsuka T, Shibuya T, Harada M, Niho Y. Cytokine gene expression in hematological malignancies. Acta Haematol Jpn 1989; 52: 1423–32.

    Google Scholar 

  26. Ikebuchi K, Clark SC, Ihle JN, Souza LM, Ogawa M. Granulocyte colony-stimulating factor enhances interleukin3-dependent proliferation of multipotential hematopoietic progenitors. Proc Natl Acad Sci USA 1988; 85: 3445–9.

    Google Scholar 

  27. Ikebuchi K, Ihle JN, Hirai Y, Wong GG, Clark SC, Ogawa M. Synergistic factors for stem cell proliferation. Further studies of the target stem cells and the mechanism of stimulating by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor. Blood 1989; 72: 2007–14.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Center, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, 812, Fukuoka, Japan

    Wataru Ikematsu & Seiichi Okamura

  2. Blood Transfusion Service, Kyushu University, Fukuoka, Japan

    Takanori Teshima, Seiji Kondo, Shigeyoshi Makino, Shouichi Inaba & Yoshiyuki Niho

  3. First Department of Internal Medicine, Kyushu University, Fukuoka, Japan

    Mine Harada & Yoshiyuki Niho

Authors
  1. Wataru Ikematsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takanori Teshima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seiji Kondo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shigeyoshi Makino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Seiichi Okamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shouichi Inaba
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mine Harada
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yoshiyuki Niho
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ikematsu, W., Teshima, T., Kondo, S. et al. Circulating CD34+ hematopoietic progenitors in the harvesting peripheral blood stem cells; enhancement by recombinant human granulocyte colony-stimulating factor. Biotherapy 5, 131–136 (1992). https://doi.org/10.1007/BF02171698

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02171698

Key words

Search

Navigation